This cross-sectional study examines the ability of school-aged children, aged 4 to 14 years, to self-collect nasal swabs for SARS-CoV-2 testing after hearing an
For each authorized COVID-19 vaccine, mix-and-match boosters elicited similar or higher antibody responses compared to getting an additional dose of the same vaccine. Emory was among 10 institutions that participated in the study.
Tags »
Emory University is participating in a study evaluating immune responses to COVID-19 vaccines, when the vaccines are administered during pregnancy or within two months after delivery.
The study, called SARS-CoV-2 Vaccines in Pregnancy and Postpartum or MOMI-Vax, is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. MOMI-Vax is being conducted by the NIAID-funded Infectious Diseases Clinical Research Consortium (IDCRC).
MOMI-Vax is open to people who have received any of the FDA-authorized COVID-19 vaccines. The early COVID-19 vaccine clinical trials generally excluded pregnant women, so there is limited data on immune responses for this special population. However, after the FDA authorized the vaccines, regulators gave people who were pregnant or soon to be pregnant the option of choosing to get the vaccines. Tens of thousands of pregnant and breastfeeding people across the country have b
Emory testing 'mix and match' booster shots for COVID-19 vaccines emory.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emory.edu Daily Mail and Mail on Sunday newspapers.